BCL2 inhibits cell adhesion, spreading, and motility by enhancing actin polymerization

Cell Research

Volumn 20, Issue 4, 2010, Pages 458-469

  Ke, Hengning ^a   Parron, Vandy I ^a   Reece, Jeff ^a   Zhang, Jennifer Y ^b   Akiyama, Steven K ^a   French, John E ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Actin polymerization; BCL2; Gelsolin; Motility

Indexed keywords

GELSOLIN; PROTEIN BCL 2;

ANIMAL; ARTICLE; CELL ADHESION; CELL MOTION; CELL STRAIN 3T3; GENETICS; HUMAN; METABOLISM; MICROFILAMENT; MOUSE; MOUSE MUTANT; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; GELSOLIN; HUMANS; MICE; MICE, KNOCKOUT; MICROFILAMENTS; NIH 3T3 CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2;

MURINAE;

EID: 77950531312     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2010.21     Document Type: Article

References (59)

1. Reed JC. Double identity for proteins of the Bcl-2 family. Nature 1997; 387:773-776.
2. Strasser A, Harris AW, Cory S. E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin- secreting cells but not T cells. Oncogene 1993; 8:1-9. (Pubitemid 23047224)
3. Kumar P, Ning Y, Polverini PJ. Endothelial cells expressing Bcl-2 promotes tumor metastasis by enhancing tumor angiogenesis, blood vessel leakiness and tumor invasion. Lab Invest 2008; 88:740-749. (Pubitemid 351896641)
4. Yilmaz A, Savas I, Dizbay Sak S, et al. Distribution of Bcl-gene expression and its prognostic value in non-small cell lung cancer. Tuberk Toraks 2005; 53:323-329.
5. Itoi T, Yamana K, Bilim V, Takahashi K, Tomita F. Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients. Br J Cancer 2004; 90:200-205. (Pubitemid 38174962)
6. Leahy DT, Mulcahy HE, O'Donoghue DP, Parfrey NA. bcl-2 protein expression is associated with better prognosis in colorectal cancer. Histopathology 1999; 35:360-367. (Pubitemid 29502355)
7. Divito KA, Berger AJ, Camp RL, et al. Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma. Cancer Res 2004; 64:8773-8777. (Pubitemid 39552096)
8. Neri A, Marrelli D, Roviello F, et al. Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer. Breast Cancer Res Treat 2006; 99:77-83. (Pubitemid 44168606)
9. Rathmell JC, Thompson CB. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 2002; 109 Suppl:S97-S107. (Pubitemid 34457855)
10. Akiyama SK, Olden K, Yamada KM. Fibronectin and integrins in invasion and metastasis. Cancer Metastasis Rev 1995; 14:173-189.
11. Bokel C, Brown NH. Integrins in development: moving on, responding to, and sticking to the extracellular matrix. Dev Cell 2002; 3:311-321.
12. Kedrin D, van Rheenen J, Hernandez L, Condeelis J, Segall JE. Cell motility and cytoskeletal regulation in invasion and metastasis. J Mammary Gland Biol Neoplasia 2007; 12:143-152. (Pubitemid 47215432)
13. Ridley AJ, Schwartz MA, Burridge K, et al. Cell migration: integrating signals from front to back. Science 2003; 302:1704-1709. (Pubitemid 37505725)
14. Webb DJ, Brown CM, Horwitz AF. Illuminating adhesion complexes in migrating cells: moving toward a bright future. Curr Opin Cell Biol 2003; 15:614-620.
15. Disanza A, Steffen A, Hertzog M, et al. Actin polymerization machinery: the finish line of signaling networks, the starting point of cellular movement. Cell Mol Life Sci 2005; 62:955-970. (Pubitemid 40655613)
16. Kassis J, Lauffenburger DA, Turner T, Wells A. Tumor invasion as dysregulated cell motility. Semin Cancer Biol 2001; 11:105-117. (Pubitemid 32423286)
17. Pantaloni D, Le Clainche C, Carlier MF. Mechanism of actinbased motility. Science 2001; 292:1502-1506.
18. Pollard TD. The cytoskeleton, cellular motility and the reductionist agenda. Nature 2003; 422:741-745.
19. Small JV, Stradal T, Vignal E, Rottner K. The lamellipodium: where motility begins. Trends Cell Biol 2002; 12:112-120. (Pubitemid 34164650)
20. Silacci P, Mazzolai L, Gauci C, et al. Gelsolin superfamily proteins: key regulators of cellular functions. Cell Mol Life Sci 2004; 61:2614-2623. (Pubitemid 39586521)
21. Linder S, Aepfelbacher M. Podosomes: adhesion hot-spots of invasive cells. Trends Cell Biol 2003; 13:376-385. (Pubitemid 36776715)
22. De Corte V, Bruyneel E, Boucherie C, et al. Gelsolin-induced epithelial cell invasion is dependent on Ras-Rac signaling. EMBO J 2002; 21:6781-6790. (Pubitemid 36014550)
23. Larson L, Arnaudeau S, Gibson B, et al. Gelsolin mediates calcium-dependent disassembly of Listeria actin tails. Proc Natl Acad Sci USA 2005; 102:1921-1926. (Pubitemid 40261988)
24. Azuma T, Witke W, Stossel TP, Hartwig JH, Kwiatkowski DJ. Gelsolin is a downstream effector of rac for fibroblast motility. EMBO J 1998; 17:1362-1370. (Pubitemid 28105515)
25. Cunningham CC, Stossel TP, Kwiatkowski DJ. Enhanced motility in NIH 3T3 fibroblasts that overexpress gelsolin. Science 1991; 251:1233-1236.
26. Arora PD, McCulloch CA. Dependence of fibroblast migration on actin severing activity of gelsolin. J Biol Chem 1996; 271:20516-20523.
27. Akiyama SK. Functional analysis of cell adhesion: quantitation of cell-matrix attachment. Methods Cell Biol 2002; 69:281-296.
28. Gildea JJ, Harding MA, Gulding KM, Theodorescu D. Transmembrane motility assay of transiently transfected cells by fluorescent cell counting and luciferase measurement. Biotechniques 2000; 29:81-86. (Pubitemid 30439420)
29. Reinhart-King CA, Dembo M, Hammer DA. The dynamics and mechanics of endothelial cell spreading. Biophys J 2005; 89:676-689. (Pubitemid 41098318)
30. Apostolova MD, Christova T, Templeton DM. Involvement of gelsolin in cadmium-induced disruption of the mesangial cell cytoskeleton. Toxicol Sci 2006; 89:465-474. (Pubitemid 43126005)
31. Li S, Guan JL, Chien S. Biochemistry and biomechanics of cell motility. Annu Rev Biomed Eng 2005; 7:105-150. (Pubitemid 41170186)
32. Zhang W, Pantschenko AG, McCarthy MB, Gronowicz G. Bone-targeted overexpression of Bcl-2 increases osteoblast adhesion and differentiation and inhibits mineralization in vitro. Calcif Tissue Int 2007; 80:111-122. (Pubitemid 46294968)
33. Sheibani N, Scheef EA, Dimaio TA, et al. Bcl-2 expression modulates cell adhesion and migration promoting branching of ureteric bud cells. J Cell Physiol 2007; 210:616-625. (Pubitemid 46185031)
34. Lambrechts A, Van Troys M, Ampe C. The actin cytoskeleton in normal and pathological cell motility. Int J Biochem Cell Biol 2004; 36:1890-1909. (Pubitemid 38760020)
35. Moissoglu K, Schwartz MA. Integrin signalling in directed cell migration. Biol Cell 2006; 98:547-555. (Pubitemid 44383371)
36. Suetsugu S, Takenawa T. Regulation of cortical actin networks in cell migration. Int Rev Cytol 2003; 2229:245-286. (Pubitemid 41782965)
37. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 1996; 84:359-369.
38. Howe A, Aplin AE, Alahari SK, Juliano RL. Integrin signaling and cell growth control. Curr Opin Cell Biol 1998; 10:220-231. (Pubitemid 28174764)
39. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110:673-687.
40. Huttenlocher A, Sandborg RR, Horwitz AF. Adhesion in cell migration. Curr Opin Cell Biol 1995; 7:697-706.
41. Ruoslahti E. Fibronectin and its integrin receptors in cancer. Adv Cancer Res 1999; 76:1-20. (Pubitemid 29190879)
42. Schwartz MA, Schaller MD, Ginsberg MH. Integrins: emerging paradigms of signal transduction. Annu Rev Cell Dev Biol 1995; 11:549-599.
43. Feldner JC, Brandt BH. Cancer cell motility - on the road from c-erbB-2 receptor steered signaling to actin reorganization. Exp Cell Res 2002; 272:93-108.
44. Zigmond SH. Beginning and ending an actin filament: control at the barbed end. Curr Top Dev Biol 2004; 63:145-188.
45. Chou J, Stolz DB, Burke NA, Watkins SC, Wells A. Distribution of gelsolin and phosphoinositol 4,5-bisphosphate in lamellipodia during EGF-induced motility. Int J Biochem Cell Biol 2002; 34:776-790. (Pubitemid 34304167)
46. Janmey PA, Stossel TP. Gelsolin-polyphosphoinositide interaction. Full expression of gelsolin-inhibiting function by polyphosphoinositides in vesicular form and inactivation by dilution, aggregation, or masking of the inositol head group. J Biol Chem 1989; 264:4825-4831.
47. Mere J, Chahinian A, Maciver SK, et al. Gelsolin binds to polyphosphoinositide-free lipid vesicles and simultaneously to actin microfilaments. Biochem J 2005; 386 (Part 1):47-56. (Pubitemid 40289223)
48. Chellaiah M, Hruska K. Osteopontin stimulates gelsolinassociated phosphoinositide levels and phosphatidylinositol triphosphate-hydroxyl kinase. Mol Biol Cell 1996; 7:743-753. (Pubitemid 26139272)
49. Ziehr J, Sheibani N, Sorenson CM. Alterations in celladhesive and migratory properties of proximal tubule and collecting duct cells from bcl-2 -/- mice. Am J Physiol Renal Physiol 2004; 287:F1154-F1163. (Pubitemid 39507224)
50. Sorenson CM. Interaction of bcl-2 with Paxillin through its BH4 domain is important during ureteric bud branching. J Biol Chem 2004; 279:11368-11374.
51. Chellaiah MA, Biswas RS, Yuen D, Alvarez UM, Hruska KA. Phosphatidylinositol 3,4,5-trisphosphate directs association of Src homology 2-containing signaling proteins with gelsolin. J Biol Chem 2001; 276:47434-47444. (Pubitemid 37373125)
52. Sorenson CM, Sheibani N. Focal adhesion kinase, paxillin, and bcl-2: analysis of expression, phosphorylation, and association during morphogenesis. Dev Dyn 1999; 215:371-382.
53. Callagy GM, Webber MJ, Pharoah PD, Caldas C. Metaanalysis confirms BCL2 is an independent prognostic marker in breast cancer. BMC Cancer 2008; 8:153. (Pubitemid 351891409)
54. Monni O, Joensuu H, Franssila K, et al. BCL2 overexpression associated with chromosomal amplification in diffuse large Bcell lymphoma. Blood 1997; 90:1168-1174. (Pubitemid 27314153)
55. Pinkas J, Martin SS, Leder P. Bcl-2-mediated cell survival promotes metastasis of EpH4 betaMEKDD mammary epithelial cells. Mol Cancer Res 2004; 2:551-556. (Pubitemid 39403383)
56. Ishido M, Ohtsubo R, Adachi T, Kunimoto M. Attenuation of both apoptotic and necrotic actions of cadmium by Bcl-2. Environ Health Perspect 2002; 110:37-42. (Pubitemid 34110700)
57. Martin SS, Leder P. Human MCF10A mammary epithelial cells undergo apoptosis following actin depolymerization that is independent of attachment and rescued by Bcl-2. Mol Cell Biol 2001; 21:6529-6536. (Pubitemid 32927420)
58. Lipton A, Klinger I, Paul D, Holley RW. Migration of mouse 3T3 fibroblasts in response to a serum factor. Proc Natl Acad Sci USA 1971; 68:2799-2801.
59. Allen PG, Janmey PA. Gelsolin displaces phalloidin from actin filaments. A new fluorescence method shows that both Ca2+ and Mg2+ affect the rate at which gelsolin severs F-actin. J Biol Chem 1994; 269:32916-32923.